|
|||||
|
|
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer |
|
| Authors: | Eustace A. J. Madden S. F. Fay J. Collins D. M. Kay E. W. Sheehan K. M. Furney S. Moran B. Fagan A. Morris P. G. Teiserskiene A. Hill A. D. Grogan L. Walshe J. M. Breathnach O. Power C. Duke D. Egan K. Gallagher W. M. O’Donovan N. Crown J. Toomey S. Hennessy B. T. |
| Affiliation: | 1.National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland ;2.Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland ;3.Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland ;4.Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland ;5.Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland ;6.Conway Institute, University College Dublin, Dublin, Ireland ;7.Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland ;8.Cancer Trials Ireland, Dublin, Ireland ;9.Department of Medical Oncology, St Vincent’s University Hospital, Dublin, Ireland ;10.Department of Radiology, Beaumont Hospital, Dublin, Ireland ;11.Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland ;12.Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland ; |
| Abstract: | Breast Cancer Research and Treatment - Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are independent predictive markers of future pathological complete response... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |